跳至主要内容
临床试验/NCT04048356
NCT04048356已完成3 期

Chlorhexidine Gluconate Versus Povidone Iodine for Vaginal Surgical Preparation for Urogynecological Procedures

University of New Mexico1 个研究点 分布在 1 个国家目标入组 137 人开始时间: 2019年7月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
137
试验地点
1
主要终点
Rate of Urinary Tract Infection

研究概览

简要总结

This is a randomized controlled trial to determine if there is a difference between chlorhexidine gluconate and povidone iodine vaginal preparations for urogynecological surgery post operative infections.

详细描述

The purpose of this randomized controlled trial is to determine whether there is a difference in efficacy of two of the most common commercially available vaginal surgical preparations. The first objective is to determine whether chlorhexidine gluconate is non-inferior to povidone iodine with respect to post-operative infections including urinary tract infections (both culture proven and empirically treated) and surgical site infections (as defined by the Centers for Disease Control). The second objective is to determine whether chlorhexidine gluconate is non-inferior to povidone iodine with respect to vulvar and vaginal irritation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Participants will be anesthetized during the intervention and will not be informed of the arm of their randomization

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female Subjects >18 years of age
  • English or Spanish speaking/reading
  • Must be able to provide informed consent
  • Undergoing urogynecologic procedures or surgery

排除标准

  • Pregnant - all patients are verified regarding pregnancy status prior to gynecologic surgical intervention at all sites of surgery - for patients who are premenopausal and have a uterus, a urine pregnancy test is administered in the preoperative setting. Pregnancy status is also determined prior to this in the office setting by interview and patient provided history prior to offering surgery to the patient.
  • Inability to return for follow-up visits
  • No concurrent need for vaginal antisepsis, such as cases of sacral neuromodulation
  • Lack of telephone
  • Known allergy to either antiseptic agent
  • Prisoners will not be eligible to participate in this study

研究组 & 干预措施

Chlorhexidine gluconate

Experimental

Chlorhexidine gluconate 2% vaginal scrub, to be applied vaginally and perineally immediately prior to surgery.

干预措施: Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery. (Drug)

Povidone Iodine

Active Comparator

Povidone iodine vaginal scrub, to be applied vaginally and perineally immediately prior to surgery.

干预措施: Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery. (Drug)

结局指标

主要结局

Rate of Urinary Tract Infection

时间窗: 2 weeks post operatively

Urinary tract infection as defined by positive urine culture of \>10,000 cfu, or empirically treated symptoms.

次要结局

  • Vaginal Irritation(Post operative day 1)
  • Rate of Surgical Site Infection(14 days postoperatively)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Chlorhexidine vs. Iodine for Vaginal Preparation in... | 临床试验